Outstanding entrepreneurship and patent awards for Arjuna Natural

Posted by Antony Kunjachan on

On the Golden Jubilee celebration of Kerala State Industrial Development Corporation (KSIDC), P. J. Kunjachan, Managing Director of Arjuna Natural Extracts Limited received the “Outstanding Entrepreneurship Award” from the honourable Chief Minister of Kerala, Oommen Chandy at Le Meridien Hotel, Cochin, on July 30, 2011.

Arjuna Natural has developed an indigenous technology to increase the bio-availability of oral curcumin by combining with essential oil of turmeric, for which the company received a US patent (Patent No: US 7,736,679 B2). The proprietary formulation of bio-available curcumin is marketed worldwide as BCM-95™.

Arjuna Natural Extracts Ltd (ANEL) is India’s leading company specialized in scientific methods of identification, separation and manufacturing of plant-based active compounds and Omega 3 fatty acids from marine and vegetable sources. ANEL also focuses on pharmacological evaluation of its products by design, monitoring and publishing of clinical studies for various applications in the dietary supplement, pharmaceutical, and cosmetic industries.

Share this post

← Older Post Newer Post →

About Curegarden

Curegarden represents a dream. A dream of sharing a happier, healthier body and quality of life with the use of nature's best ingredients. Botanics, when extracted for their bio-active compounds, offer a most effective approach to improving well-being and quality of life. It is based on the belief that botanical of the highest quality would have a positive effect — without any negative side effects — on people's health. Over the years,we have seen and experienced personally the wonderful benefits of these high quality botanical products and are delighted to share them with others.

About Arjuna Naturals

Arjuna Natural Ltd is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for over two decades. With customers in around 40 countries, the company has close to 50 patents to its credit of which majority are commercialized globally. The company has R&D tie ups with international universities from Australia, US and Japan. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.